Related Experiment Video

Updated: Jul 14, 2026

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

Could rhG-CSF induction of tetraploidy contribute to leukemogenesis in healthy donors?

C Kaplinsky, L Trakhtenbrot, S Izraeli

    British Journal of Haematology
    |June 26, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
    10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
    12:04

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

    Published on: March 10, 2023

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
    07:01

    Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

    Published on: May 2, 2025

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
    10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
    12:04

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

    Published on: March 10, 2023

    Related Concept Videos

    Regulation of Hematopoietic Stem Cells01:01

    Regulation of Hematopoietic Stem Cells

    All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

    Articles linked to this work by shared authors, journal, and citation graph.

    The KMT2A recombinome of acute leukemias in 2023.

    Leukemia·2023

    The MLL recombinome of acute leukemias in 2017.

    Leukemia·2017

    The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

    Leukemia·2017

    Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications.

    Oncogene·2017

    The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.

    Leukemia·2016

    MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs.

    Bioconjugate chemistry·2015

    Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.

    British journal of haematology·2026

    Prospective evaluation of serum methotrexate pharmacokinetics following intrathecal methotrexate in acute lymphoblastic leukaemia.

    British journal of haematology·2026

    Mogamulizumab efficacy on the skin compartment of cutaneous T-cell lymphomas based on longitudinal analysis.

    British journal of haematology·2026

    CAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.

    British journal of haematology·2026

    Patient-specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancy.

    British journal of haematology·2026

    A real-world multi-institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B-cell acute lymphoblastic leukaemia.

    British journal of haematology·2026

    Functional ovarian reserve in women with Hodgkin and non-Hodgkin lymphomas.

    Frontiers in oncology·2026

    A spectrum of tumorigenesis in an IDH1-mosaic patient with Ollier disease, acute myeloid leukaemia, and parathyroid adenoma.

    Frontiers in genetics·2026

    TIM-3 Functions as an Activator of NK Cells in GBM and Can Be Upregulated by Torin-1: Implications for Exogenous NK Cell Transplantation.

    Immunology·2026

    Epinephrine-mediated sensitization of thioredoxin 1 enhances chlorpromazine protection against acute hepatotoxicity.

    BMC pharmacology & toxicology·2026

    Ferroptosis in health and disease.

    Molecular biomedicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us